Kinarus Therapeutics Holding AG

PRFN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PRFN.SW stands at 0. In comparison, DPW.SW has a market cap of 42.1B. Regarding current trading prices, PRFN.SW is priced at CHF 0.04, while DPW.SW trades at CHF 31.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PRFN.SW currently has a P/E ratio of -36.20, whereas DPW.SW's P/E ratio is 7.34. In terms of profitability, PRFN.SW's ROE is -0.42%, compared to DPW.SW's ROE of +0.15%. Regarding short-term risk, Volatility data is not available for a full comparison. PRFN.SW has daily volatility of 12.77 and DPW.SW has daily volatility of N/A.Check DPW.SW's competition here

PRFN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PRFN.SW stands at 0. In comparison, FHZN.SW has a market cap of 7.8B. Regarding current trading prices, PRFN.SW is priced at CHF 0.04, while FHZN.SW trades at CHF 253.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PRFN.SW currently has a P/E ratio of -36.20, whereas FHZN.SW's P/E ratio is 22.52. In terms of profitability, PRFN.SW's ROE is -0.42%, compared to FHZN.SW's ROE of +0.11%. Regarding short-term risk, PRFN.SW is more volatile compared to FHZN.SW. This indicates potentially higher risk in terms of short-term price fluctuations for PRFN.SW.Check FHZN.SW's competition here

PRFN.SW plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PRFN.SW stands at 0. In comparison, LHA.SW has a market cap of 2.9B. Regarding current trading prices, PRFN.SW is priced at CHF 0.04, while LHA.SW trades at CHF 7.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PRFN.SW currently has a P/E ratio of -36.20, whereas LHA.SW's P/E ratio is 6.88. In terms of profitability, PRFN.SW's ROE is -0.42%, compared to LHA.SW's ROE of +0.12%. Regarding short-term risk, PRFN.SW is more volatile compared to LHA.SW. This indicates potentially higher risk in terms of short-term price fluctuations for PRFN.SW.Check LHA.SW's competition here